TrianglePUBLICATIONS · 31513481
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2019 Nov 1
- First author
- Mascarenhas L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mascarenhas L
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Hingorani P
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Lyden ER
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Indelicato DJ
- type
- Author
- name
- Kao SC
- type
- Author
- name
- Dasgupta R
- type
- Author
- name
- Spunt SL
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Hawkins DS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mascarenhas L
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Hingorani P
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Lyden ER
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Indelicato DJ
- type
- Author
- name
- Kao SC
- type
- Author
- name
- Dasgupta R
- type
- Author
- name
- Spunt SL
- type
- Author
- name
- Meyer WH
- type
- Author
- name
- Hawkins DS
- type
- Author
- bibliography ids
- nci-bib-2d0366fed2b5805ac03c54b8
- book metadata
- content sha256
- acec3236ad89944552038ef17856fff8eb096e87958d4cd257cee7b1ce738bfd
- document type
- citation
- dois
- 10.1200/JCO.19.00576
- electronic publication date
- display
- 2019 Sep 12
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31513481
- immutable id
- pubmed:31513481@acec3236ad89944552038ef17856fff8eb096e87958d4cd257cee7b1ce738bfd
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2866-2874
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 31513481
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- 8d18f9e0ad9647ae3a0f81baed71993bacff22c6af24c99ef66b587086d1c222
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Nov 1
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase II
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Preserved source evidence · Not medical advice